The administrative core will be responsible for all administrative activities of the tPPG and will insure that the program operates according to its objectives and NIH guidelines. The core will be responsible for coordinating all fiscal management and personnel management. The core will also coordinate and schedule regular monthly research conferences, visits by external advisors, meetings of internal advisors and the annual tPPG retreat. The core will also be responsible for the timely renewal and modification of animal research, human research, bio-safety and readiation safety approvals, for insuring the timely training of all new and existing personnel in safe and ethical lab practices and for the coordination and preparation of the annual progress reports. The core will act as the intermediary for all components of the program and to the funding agency to effectively administer and integrate all components of the program and to provide clear, effective and succinct communication.

Public Health Relevance

The core will provide the necessary administrative back-up to maintain effective communication among each of the projects and cores in this grant and between these projects and cores and groups of internal and external advisors and staff at the NHLBI

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL108794-01A1
Application #
8401278
Study Section
Special Emphasis Panel (ZHL1-CSR-Q (M1))
Project Start
Project End
Budget Start
2012-08-09
Budget End
2013-07-31
Support Year
1
Fiscal Year
2012
Total Cost
$166,561
Indirect Cost
$60,132
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Feldman, Hannah C; Tong, Michael; Wang, Likun et al. (2016) Structural and Functional Analysis of the Allosteric Inhibition of IRE1α with ATP-Competitive Ligands. ACS Chem Biol 11:2195-205
DePianto, Daryle J; Chandriani, Sanjay; Abbas, Alexander R et al. (2015) Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax 70:48-56
Reed, Nilgun I; Jo, Hyunil; Chen, Chun et al. (2015) The αvβ1 integrin plays a critical in vivo role in tissue fibrosis. Sci Transl Med 7:288ra79
Assayag, Deborah; Vittinghoff, Eric; Ryerson, Christopher J et al. (2015) The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis. Respir Med 109:1058-62
Yang, Jibing; Velikoff, Miranda; Agarwal, Manisha et al. (2015) Overexpression of inhibitor of DNA-binding 2 attenuates pulmonary fibrosis through regulation of c-Abl and Twist. Am J Pathol 185:1001-11
Wolters, Paul J; Collard, Harold R; Jones, Kirk D (2014) Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol 9:157-79
Ghosh, Rajarshi; Wang, Likun; Wang, Eric S et al. (2014) Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress. Cell 158:534-48
Stuart, Bridget D; Lee, Joyce S; Kozlitina, Julia et al. (2014) Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. Lancet Respir Med 2:557-65
Xi, Ying; Tan, Kevin; Brumwell, Alexis N et al. (2014) Inhibition of epithelial-to-mesenchymal transition and pulmonary fibrosis by methacycline. Am J Respir Cell Mol Biol 50:51-60
Travis, Mark A; Sheppard, Dean (2014) TGF-β activation and function in immunity. Annu Rev Immunol 32:51-82

Showing the most recent 10 out of 15 publications